CoChat

Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma

Open access
Marin-Bejar, Oskar, Rogiers, Aljosja, Dewaele, Michael, Femel, Julia, Karras, Panagiotis, Pozniak, Joanna, Bervoets, Greet, Van Raemdonck, Nina, Pedri, Dennis, Swings, Toon, Demeulemeester, Jonas, Borght, Sara Vander, Lehnert, Stefan, Bosisio, Francesca, van den Oord, Joost J., Bempt, Isabelle Vanden, Lambrechts, Diether, Voet, Thierry, Bechter, Oliver, Rizos, Helen, Levesque, Mitchell P., Leucci, Eleonora, Lund, Amanda W., Rambow, Florian, Marine, Jean-Christophe · 2021 · Cancer Cell
Cited by 141

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Therapy resistance arises from heterogeneous drug-tolerant persister cells or minimal residual disease (MRD) through genetic and nongenetic mechanisms. A key question is whether specific molecular features of the MRD ecosystem determine which of these two distinct trajectories will eventually prevail. We show that, in melanoma exposed to mitogen-activated protein kinase therapeutics, emergence of a transient neural crest stem cell (NCSC) population in MRD concurs with the development of nongenetic resistance. This increase relies on a glial cell line-derived neurotrophic factor-dependent signaling cascade, which activates the AKT survival pathway in a focal adhesion kinase (FAK)-dependent manner. Ablation of the NCSC population through FAK inhibition delays relapse in patient-derived tumor xenografts. Strikingly, all tumors that ultimately escape this treatment exhibit resistance-conferring genetic alterations and increased sensitivity to extracellular signal-regulated kinase inhibition. These findings identify an approach that abrogates the nongenetic resistance trajectory in melanoma and demonstrate that the cellular composition of MRD deterministically imposes distinct drug resistance evolutionary paths.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2021.05.015

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 141

Metadata

Authors
Marin-Bejar, O., Rogiers, A., Dewaele, M., Femel, J., Karras, P., Pozniak, J., Bervoets, G., Van Raemdonck, N., Pedri, D., Swings, T., Demeulemeester, J., Borght, S. V., Lehnert, S., Bosisio, F., van den Oord, J. J., Bempt, I. V., Lambrechts, D., Voet, T., Bechter, O., Rizos, H., Levesque, M. P., Leucci, E., Lund, A. W., Rambow, F., & Marine, J.-C.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2021-08
Volume
39
Issue
8
Pages
1135-1149.e8
ISSN
1535-6108 (ISSN-L)
OpenAlex
W3167360675
Cited by
141
References
22
FWCI
7.11
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.